Scott F. Drees

Scott F. Drees

Director Ejecutivo en Neurolief Ltd. .

67 años
Health Technology
Consumer Services
Electronic Technology

Perfil

Scott F.
Drees
currently works at Neurolief Ltd., as Chief Executive Officer & Director from 2022 and National Pain Foundation, as Member.
Mr. Drees also formerly worked at Nuvectra Corp., as Chief Executive Officer & Director from 2016 to 2019, Neuromodulation Ventures LLC, as President & Chief Executive Officer from 2008 to 2015, Neuros Medical, Inc., as Director, Johnson & Johnson, as Principal, Advanced Neuromodulation Systems, Inc., as Executive Vice President-Sales & Marketing, St. Jude Medical LLC, as Principal, Boston Scientific Corp., as Principal, and Global Pain Initiative, as Member.
Mr. Drees received his undergraduate degree from St. Joseph's University.

Cargos activos de Scott F. Drees

EmpresasCargoInicio
Corporate Officer/Principal -
Director Ejecutivo 13/12/2022
Todos los cargos activos de Scott F. Drees

Antiguos cargos conocidos de Scott F. Drees.

EmpresasCargoFin
NUVECTRA CORPORATION Director Ejecutivo 31/01/2019
Director Ejecutivo 01/07/2015
Corporate Officer/Principal -
ST JUDE MEDICAL INC Corporate Officer/Principal -
JOHNSON & JOHNSON Corporate Officer/Principal -
Ver el detalle de la experiencia de Scott F. Drees.

Formación de Scott F. Drees.

St. Joseph's University Undergraduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Scott F. Drees.

Relaciones

4

Relaciones de 1er grado

11

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas2
BOSTON SCIENTIFIC CORPORATION

Health Technology

JOHNSON & JOHNSON

Health Technology

Empresas privadas8

Health Technology

Electronic Technology

Finance

Health Technology

Health Technology

Commercial Services

Technology Services

Producer Manufacturing

Ver las conexiones de la empresa
-40% Oferta por Tiempo Limitado: Nuestras suscripciones le guían hacia las mejores inversiones del mañana.
APROVÉCHELO AHORA